Evidence map›Paper›PMID 34204296›Full record

ArticleNanomaterials (Basel, Switzerland)2021

Biotransformation of Silver Nanoparticles into Oro-Gastrointestinal Tract by Integrated In Vitro Testing Assay: Generation of Exposure-Dependent Physical Descriptors for Nanomaterial Grouping.

Catherine Carnovale, Daniela Guarnieri, Luisana Di Cristo, Isabella De Angelis, Giulia Veronesi, Alice Scarpellini, Maria Ada Malvindi, Flavia Barone, Pier Paolo Pompa, Stefania Sabella

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Catherine CarnovaleIstituto Italiano Di Tecnologia, Nanoregulatory Platform, Drug Discovery and Development Department, 16163 Genova, Italy.
Daniela GuarnieriDipartimento di Chimica e Biologia "A. Zambelli", Università di Salerno, Via Giovanni Paolo II 132, Fisciano, 84084 Salerno, Italy.ORCID 0000-0002-0947-7724
Luisana Di CristoIstituto Italiano Di Tecnologia, Nanoregulatory Platform, Drug Discovery and Development Department, 16163 Genova, Italy.ORCID 0000-0002-5685-4676
Isabella De AngelisIstituto Superiore di Sanità (ISS), 00161 Rome, Italy.
Giulia VeronesiLaboratory of Chemistry and Biology of Metals (CBM), University Grenoble Alpes/CNRS/CEA, 38000 Grenoble, France.ORCID 0000-0001-9228-6082
Alice ScarpelliniElectron Microscopy Facility, Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy.
Maria Ada MalvindiHiQ-Nano, s.r.l. Via Barsanti, Arnesano, 73010 Lecce, Italy.
Flavia BaroneIstituto Superiore di Sanità (ISS), 00161 Rome, Italy.
Pier Paolo PompaNanobiointeractions & Nanodiagnostics, Istituto Italiano di Tecnologia (IIT), Via Morego 30, 16163 Genova, Italy.ORCID 0000-0001-7549-0612
Stefania SabellaIstituto Italiano Di Tecnologia, Nanoregulatory Platform, Drug Discovery and Development Department, 16163 Genova, Italy.
Italian Institute of Technology · ITIstituto Superiore di Sanità · ITCentre National de la Recherche Scientifique · FRUniversity of Salerno · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Grouping approaches of nanomaterials have the potential to facilitate high throughput and cost effective nanomaterial screening. However, an effective grouping of nanomaterials hinges on the application of suitable physicochemical descriptors to identify similarities. To address the problem, we developed an integrated testing approach coupling acellular and cellular phases, to study the full life cycle of ingested silver nanoparticles (NPs) and silver salts in the oro-gastrointestinal (OGI) tract including their impact on cellular uptake and integrity. This approach enables the derivation of exposure-dependent physical descriptors (EDPDs) upon biotransformation of undigested nanoparticles, digested nanoparticles and digested silver salts. These descriptors are identified in: size, crystallinity, chemistry of the core material, dissolution, high and low molecular weight Ag-biomolecule soluble complexes, and are compared in terms of similarities in a grouping hypothesis. Experimental results indicate that digested silver nanoparticles are neither similar to pristine nanoparticles nor completely similar to digested silver salts, due to the presence of different chemical nanoforms (silver and silver chloride nanocrystals), which were characterized in terms of their interactions with the digestive matrices. Interestingly, the cellular responses observed in the cellular phase of the integrated assay (uptake and inflammation) are also similar for the digested samples, clearly indicating a possible role of the soluble fraction of silver complexes. This study highlights the importance of quantifying exposure-related physical descriptors to advance grouping of NPs based on structural similarities.

Indexed as

bioavailabilityconsecutive dissolution testexposure dependent physical descriptorsgroupinghuman digestionoral exposuresilver nanoparticles

Identifiers

PMID34204296
PMCPMC8233905
OpenAlexW3172257615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.